Hankook Cosmetics Co., Ltd. (123690.KS)
ValueMarkers Composite Index
32% above intrinsic value ($4)
Hankook Cosmetics Co., Ltd. (123690.KS) — VMCI valuation read
Headline read on 123690.KS: VMCI of 56/100 versus a broad-market sample median of 50. The 6-point above-median position is what makes Hankook Cosmetics Co., Ltd. a relative-value candidate in the mid-cap cohort, before any pillar-level review.
Form 4 filings on 123690.KS: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.
**Investor frame.** Three reads on 123690.KS: value (123690.KS trades at 27.0x earnings, 50% above the sector median of 18.0x), quality (ROIC of 15.0% sits 5.0pp above the sector median (10.0%)), and risk (net debt to EBITDA of -0.9x leaves covenant headroom). The value read also implies an EV/EBITDA gap of +4.0x against the sector 12.0x baseline.
123690.KS rose 1.4% over the trailing 7 days, with a +0.6% read on a 30-day basis.
Hankook Cosmetics Co., Ltd. produces and sells cosmetics in South Korea and internationally. It offers its products under the Sansim, Hyoum, Ossion, Jutanhak, Secret Nature, Calli, GENERTE, A3F[on], Temptation, CONTINUE, Chess The Classic, CLASSYGIRL, Beautri, BEAUTENIQUE, Dr Medix, and Parapam brands. The company was founded in 1961 and is based in Seoul, South Korea.
Related Stocks
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.